Patents by Inventor Richard Heller

Richard Heller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6937890
    Abstract: The manipulator includes a support and at least one member affixed to and extending away from the support. The member has at least two differentially activatable areas of conductivity. The members are configured to establish a first electromagnetic field in vivo between selected areas of conductivity sufficient to manipulate a molecule relative to a target tissue and to establish a second, typically higher, electromagnetic field sufficient to cause transient permeability of a cell membrane within the target tissue. Restraining means are also described for restricting movement of the members with relation to each other. One method of using the device is for enhancing the delivery of a molecule into a tissue site; another is for poration of the tissue alone or in combination with the migration. The target tissue may include a tumor, organ, or wound site.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: August 30, 2005
    Assignee: University of South Florida
    Inventors: Mark J. Jaroszeski, Richard Gilbert, Richard Heller
  • Patent number: 6929949
    Abstract: The present invention provides a method and apparatus adapted to facilitate the entry of a preselected molecule into the intracellular space of a cellular sample through the use of ions generated by a corona charge source. With the present method and apparatus, molecules are manipulated within cells and in the extracellular space surrounding the cells. Manipulation enhances the permeability of cell barriers to allow the subsequent introduction of molecules of interest into the interior of a cell.
    Type: Grant
    Filed: June 13, 2003
    Date of Patent: August 16, 2005
    Assignee: University of South Florida
    Inventors: Drew Hoff, Mark J. Jaroszeski, Richard Gilbert, Richard Heller
  • Publication number: 20050076335
    Abstract: A method is presented for processing data in a multithreaded application to alleviate impaired or substandard performance conditions. Work items that are pending processing by the multithreaded application are placed into a data structure. The work items are processed by a plurality of threads within the multithreaded application in accordance with a first algorithm, e.g., first-in first-out (FIFO). A thread within the multithreaded application is configured apart from the plurality of threads such that it processes work items in accordance with a second algorithm that differs from the first algorithm, thereby avoiding the impairing condition. For example, the thread may process a pending work item only if it has a particular characteristic. The thread restricts its own processing of work items by intermittently evaluating workflow conditions for the plurality of threads; if the workflow conditions improve or are unimpaired, then the thread does not process any work items.
    Type: Application
    Filed: October 2, 2003
    Publication date: April 7, 2005
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Mark Cavage, Kristin Hazlewood, Richard Heller, Gary Williams
  • Publication number: 20050054969
    Abstract: The present invention is a device for electromanipulation of chemical species in vivo relative to a target tissue including a nonconductive, conformable array base adapted to be placed coincident to the target tissue, a plurality of electrode elements projecting from the array base towards the target tissue, the electrode elements addressable individually, an electrical source coupled to the plurality of electrodes, a control means interposed between the electrical source and the plurality of electrode elements and in circuit communication therein, the control means adapted to establish an electrical potential between at least two electrodes, and a delivery means adapted to introduce chemical species to the target tissue.
    Type: Application
    Filed: September 10, 2003
    Publication date: March 10, 2005
    Applicant: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Andrew Hoff, Richard Gilbert, Richard Heller, Mark Jaroszeski
  • Patent number: 6778853
    Abstract: A device for manipulating a molecule in vivo relative to a target tissue includes at least one elongated member having at least two discrete and separately activatable electrodes separated by an insulating material interposed therebetween. The electrodes are configured to establish at least one of a first electromagnetic field between selected electrodes sufficient to manipulate a molecule relative to a target tissue and a second, typically higher-level, electromagnetic field sufficient to cause transient permeability of a cell membrane within the target tissue. A third electromagnetic field may also be applied to cause further translation of the molecule into an electropermeabilized cell and/or manipulated with respect to the tissue. Thus three-dimensional manipulation of the molecule relative to the target tissue may be effected to optimize a desired positioning thereof, such as entry into a cell.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: August 17, 2004
    Assignee: University of South Florida
    Inventors: Richard Heller, Richard Gilbert, Mark J. Jaroszeski
  • Patent number: 6714816
    Abstract: The electroporation system and method combine pulses having different characteristics for delivering molecules to cells in vivo. The pulses include a high-intensity pulse for inducing electroporation and a low-intensity pulse to induce electrophoretic molecule movement within an interstitial space, molecule adherence to a cell membrane, and electrophoretic movement of the molecule through the permeabilized membrane. The use of a high-intensity and a low-intensity pulse achieves improved delivery; reduction of intensity and/or duration of pulses for inducing electroporation; and decreased muscle stimulation, tissue damage, and patient discomfort.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: March 30, 2004
    Assignee: University of South Florida
    Inventors: Richard Heller, Richard Gilbert, Mark J. Jaroszeski, Loree C. Heller, Melinda L. Lucas
  • Publication number: 20030216784
    Abstract: The present invention is a method of electromanipulation for effecting substantially simultaneous electroporation and electromigration of molecules into cells by applying to a cellular target a preselected electrical waveform. The preselected electrical waveform may be formed of at least one curved or linear component either increasing or decreasing in amplitude as a function of time. In a preferred embodiment of the invention the at least one component has a duration no greater than five minutes and a maximum amplitude no greater than 10,000 V/cm. Alternatively, the waveform may also include a substantially constant amplitude component interposed between the increasing and decreasing components. The substantially constant amplitude component may also be applied prior or subsequent to the at least one component.
    Type: Application
    Filed: August 5, 2002
    Publication date: November 20, 2003
    Inventors: Richard Heller, Richard Gilbert, Mark J. Jaroszeski
  • Publication number: 20030141294
    Abstract: An apparatus for producing cell electrofusion is provided. The apparatus for producing cell fusion, the apparatus including a chamber including an insert and a cuvette, the chamber also includes a substrate, a fluid medium for containing cells to be fused in said chamber, a device for inducing migration of cells in said chamber toward one side of said substrate, and a device for inducing fusion of at least a portion of the cells.
    Type: Application
    Filed: January 28, 2002
    Publication date: July 31, 2003
    Inventors: Mark J. Jaroszeski, Richard A. Gilbert, Richard Heller
  • Patent number: 6569149
    Abstract: A method for in vivo electrotherapy, or electroporation-mediated therapy, using a needle array apparatus is provided. Treatment of tumors with a combination of electroporation using the apparatus of the invention, and a chemotherapeutic agent, caused regression of tumors in vivo.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: May 27, 2003
    Assignees: Genetronics, Inc., The University of South Florida Research Foundation, Inc.
    Inventors: S. B. Dev, Gunter A. Hofmann, Richard A. Gilbert, Richard Heller, Mark J. Jaroszeski
  • Publication number: 20030044985
    Abstract: A method for facilitating a delivery of a molecule into an interior space of a cell includes the steps of introducing a molecule into a target tissue comprising a cell and applying a substantially continuous low-level electric field to the target tissue. The field is applied for a duration sufficient to effect a change in porosity the cell of the target tissue sufficient to facilitate an entry of a desired molecule into an interior of the cell.
    Type: Application
    Filed: August 24, 2001
    Publication date: March 6, 2003
    Inventors: Mark J. Jaroszeski, Richard Gilbert, Richard Heller
  • Publication number: 20020198485
    Abstract: A method for in vivo electrotherapy, or electroporation-mediated therapy, using a needle array apparatus is provided. Treatment of tumors with a combination of electroporation using the apparatus of the invention, and a chemotherapeutic agent, caused regression of tumors in vivo.
    Type: Application
    Filed: June 21, 2002
    Publication date: December 26, 2002
    Applicant: GENETRONICS, INC.
    Inventors: Sukhendu B. Dev, Gunter A. Hofmann, Richard A. Gilbert, Richard Heller, Mark J. Jaroszeski
  • Patent number: 6451002
    Abstract: A method for in vivo electrotherapy, or electroporation-mediated therapy, using a needle array apparatus is provided. Treatment of tumors with a combination of electroporation using the apparatus of the invention, and a chemotherapeutic agent, caused regression of tumors in vivo.
    Type: Grant
    Filed: October 25, 1999
    Date of Patent: September 17, 2002
    Assignee: Genetronics, Inc.
    Inventors: Sukhendo B. Dev, Gunter A. Hofmann, Richard A. Gilbert, Yasuhiko Hayakawa, Richard Heller, Mark J. Jaroszeski
  • Patent number: 6418341
    Abstract: A method for in vivo electrotherapy, or electroporation-mediated therapy, using a needle array apparatus is provided. Treatment of tumors with a combination of electroporation using the apparatus of the invention, and a chemotherapeutic agent, caused regression of tumors in vivo.
    Type: Grant
    Filed: April 18, 2000
    Date of Patent: July 9, 2002
    Assignee: Genetronics, Inc.
    Inventors: Gunter A. Hofmann, Richard A. Gilbert, Richard Heller, Mark J. Jaroszeski
  • Publication number: 20020042588
    Abstract: The manipulator includes a support and at least one member affixed to and extending away from the support. The member has at least two differentially activatable areas of conductivity. The members are configured to establish a first electromagnetic field in vivo between selected areas of conductivity sufficient to manipulate a molecule relative to a target tissue and to establish a second, typically higher, electromagnetic field sufficient to cause transient permeability of a cell membrane within the target tissue. Restraining means are also described for restricting movement of the members with relation to each other. One method of using the device is for enhancing the delivery of a molecule into a tissue site; another is for poration of the tissue alone or in combination with the migration. The target tissue may include a tumor, organ, or wound site.
    Type: Application
    Filed: January 30, 2001
    Publication date: April 11, 2002
    Inventors: Mark J. Jaroszeski, Richard Gilbert, Richard Heller
  • Patent number: 6355485
    Abstract: A new and useful apparatus for producing cell electrofusion is provided. The apparatus comprises: a. a chamber with a substrate disposed therein, b. means for directing the cells to be fused toward one side of the substrate; and c. a device for inducing fusion of the portion of the cells.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: March 12, 2002
    Assignee: University of South Florida
    Inventors: Mark J. Jaroszeski, Richard A. Gilbert, Richard Heller
  • Patent number: 6314316
    Abstract: The manipulator includes a support and at least one member affixed to and extending away from the support. The member has at least two differentially activatable electrodes. The electrodes are configured to establish a first electromagnetic field in vivo between selected electrodes sufficient to manipulate a molecule relative to a target tissue and to establish a second, typically higher, electromagnetic field sufficient to cause transient permeability of a cell membrane within the target tissue. One method of using the device is for enhancing the delivery of a molecule into a tissue site. In a related embodiment the device may be used to cause the electromigration of at least two components of a multicomponent reactive system into apposition to permit a reaction to occur at a desired target tissue site. The target tissue may comprise a tumor, organ, or wound site.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: November 6, 2001
    Assignee: University of South Florida
    Inventors: Richard Gilbert, Mark Jaroszeski, Richard Heller
  • Patent number: 6221665
    Abstract: A new and useful apparatus for producing cell electrofusion is provided. The apparatus comprises: a. a chamber with a substrate disposed therein, b. means for directing the cells to be fused toward one side of the substrate in so that the cells in the fluid medium are retained against the one side of the substrate with a significant portion of the cells in cell-to-cell contact with each other along said one side of the substrate, and c. a device for inducing fusion of the portion of the cells in cell-to-cell contact with each other along the predetermined portion of the one side of the substrate.
    Type: Grant
    Filed: June 8, 1999
    Date of Patent: April 24, 2001
    Assignee: University of South Florida
    Inventors: Mark J. Jaroszeski, Richard A. Gilbert, Richard Heller
  • Patent number: 6135990
    Abstract: A device for manipulating a molecule in vivo relative to a target tissue in three dimensions includes a support and at least one member affixed to and extending away from the support. The member has at least two discrete and separately activatable electrodes. The electrodes are configured to establish a first electromagnetic field between selected electrodes sufficient to manipulate a molecule relative to a target tissue. The electrodes are further configured to establish a second, typically higher-level, electromagnetic field sufficient to cause transient permeability of a cell membrane within the target tissue. A third electromagnetic field may also be applied to cause further translation of the molecule into an electropermeabilized cell and/or manipulated with respect to the tissue. Thus three-dimensional manipulation of the molecule relative to the target tissue is effected to optimize a desired positioning thereof, such as entry into a cell.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: October 24, 2000
    Assignee: University of South Florida
    Inventors: Richard Heller, Richard Gilbert, Mark Jaroszeski
  • Patent number: 5830460
    Abstract: A method of producing a sustained localized brain immunosuppressive effect in localized tissues is achieved by transplanting Sertoli cells proximate to the brain tissue.
    Type: Grant
    Filed: March 13, 1995
    Date of Patent: November 3, 1998
    Assignee: University of South Florida
    Inventors: Paul R. Sanberg, Don F. Cameron, Cesario V. Borlongan, Richard Heller
  • Patent number: 5827736
    Abstract: A purified and isolated Sertoli cell and secretory cell hybrid, or an aggregate of these two cells, wherein the secretory cells preferably are pancreatic islet cells and chromaffin cells characterized by beinga) capable of survival in situ after transplantation;b) able to provide immunoprotection for the hybrid cells when transplanted; andc) able to provide a mechanism for prolonged viability and cellular functionality of the transplanted hybrid cells wherein the hybrid maintains both the immunoprotection characteristics of the Sertoli cell and the secretory function of the secretory cell.
    Type: Grant
    Filed: January 9, 1997
    Date of Patent: October 27, 1998
    Assignee: University of South Florida
    Inventors: Richard Heller, Don F. Cameron, Paul R. Sanberg, Mark J. Jaroszeski